Navigation Links
FDA Begins Process To Remove Breast Cancer Indication From Avastin Label
Date:12/16/2010

SILVER SPRING, Md., Dec. 16, 2010 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

The agency is making this recommendation after reviewing the results of four clinical studies of Avastin in women with breast cancer and determining that the data indicate that the drug does not prolong overall survival in breast cancer patients or provide a sufficient benefit in slowing disease progression to outweigh the significant risk to patients. These risks include severe high blood pressure; bleeding and hemorrhage; the development of perforations (or "holes") in the body, including in the nose, stomach, and intestines; and heart attack or heart failure.

In July 2010, after reviewing all available data an independent advisory committee, composed primarily of oncologists, voted 12-1 to remove the breast cancer indication from Avastin's label.  

"After careful review of the clinical data, we are recommending that the breast cancer indication for Avastin be removed based on evidence from four independent studies," Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research. "Subsequent studies failed to confirm the benefit observed in the original trial. None of the studies demonstrated that patients receiving Avastin lived longer and patients receiving Avastin experienced a significant increase in serious side effects. The limited effects of Avastin combined with the significant risks led us to this difficult decision. The results of these studies are disappointing. We encourage the company to conduct additional research to identify if there may be select groups of patients who migh
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line
2. CryoLife Begins Distribution of Blood-Clotting Agent PerClot® in Europe
3. BiondVax Begins Phase IIa Study for Universal Flu Vaccine
4. LIG Assets, Inc. Begins Distribution and Marketing of Unique CPAP Mask Cleaner
5. China PharmaHub Corp. Begins Trading Under Stock Symbol CPHB Instead of WRLC
6. Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
7. Sysmex America Begins Distribution of CellaVision® DM1200
8. Renhuang Begins Trading on NYSE Amex
9. Par Pharmaceutical Begins Shipment of Generic Zegerid®
10. Curemark Begins Autism Trials at Two More Sites
11. ThromboGenics and BioInvent to Receive EUR10 Million Milestone as Partner Roche Begins New Clinical Study with TB-403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... today announced that it will report its 2013 first quarter earnings on ... Ed Borkowski , CFO, will host an analyst and ... To participate in the conference call within the U.S. and ... conference call outside the U.S. and Canada , dial ... Participants should dial in 10 minutes prior to the start of the ...
(Date:5/17/2013)... MONTVALE, N.J. , May 17, 2013 /PRNewswire/ ... imaging, and Hitachi-Aloka Medical, a global leader in ... the two global companies to enable further innovation ... For years, the Hitachi-Aloka ultrasound systems and PENTAX ... world,s most trusted families of EUS systems. This ...
(Date:5/17/2013)... Mass. , May 17, 2013  Boston Scientific ... participate at the annual EuroPCR Scientific Program May 21-24 ... are pleased to present a particularly rich and diversified ... Keith Dawkins , M.D., global chief medical ... trials will be presented, including the NG PROMUS trial, ...
Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
... Pharmaceuticals Inc. (NASDAQ: CPIX) today announced ... Fast 500 ™ list, an annual ranking of ... clean technology companies in North America. Rankings are based ... period from 2006 to 2010. Cumberland Pharmaceuticals grew 158% ...
... CLEVELAND, Oct. 20, 2011 A 76-year-old man suffering ... years is now pain-free, thanks to the world,s first ... Therapeutics. (Logo: http://photos.prnewswire.com/prnh/20111020/DC90730LOGO )   ... and the patient was treated at Carolinas Rehabilitation in ...
Cached Medicine Technology:Cumberland Pharmaceuticals Ranks as one of the Fastest Growing Companies in North America on Deloitte's 2011 Technology Fast 500™ 2Cumberland Pharmaceuticals Ranks as one of the Fastest Growing Companies in North America on Deloitte's 2011 Technology Fast 500™ 3World's First Implantation of SPR™ System for Chronic Pain 2World's First Implantation of SPR™ System for Chronic Pain 3
(Date:5/18/2013)... (PRWEB) May 18, 2013 TheBeautyPlace.com answers ... Pattern hair loss is not a result of stress, ... to Men’s Fitness Magazine, 70% of men suffer from ... Strength is renowned for hair transplant surgery, but ... male pattern baldness known as Bosley Professional Strength. Their ...
(Date:5/18/2013)... New York (PRWEB) May 18, 2013 ... mount in courts throughout the country, Bernstein Liebhard LLP ... hip replacement patients often suffer tissue damage before they ... study, which according to Science Daily will appear in ... hip replacement recipients underwent MRI screens of their hips. ...
(Date:5/18/2013)... Mobile, AL (PRWEB) May 18, 2013 ... several malignant tumors, the association between obesity and esophageal ... that for other obesity-related tumors. As reported ... obese people are almost twice as likely as those ... disease. Although the relationship between obesity and esophageal cancer ...
(Date:5/18/2013)... “Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, Respiratory ... Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive Landscape ... market drivers, restraints, and opportunities in North America, Europe, ... 147 market data tables ... 318 pagesand in-depth TOC of “Sleep Apnea Diagnostic ...
(Date:5/18/2013)... Miami, Florida (PRWEB) May 18, 2013 ... that’s also known as “Spice” or “K2” are landing ... is helping to curb this drug epidemic with ... and synthetic marijuana. , According to research from the ... the second-most popular illegal drug among American teenagers. In ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2
... according to CDC , TUESDAY, Sept. 8 (HealthDay News) ... effective in treating the H1N1 swine flu, should be taken ... high risk for complications from the disease, U.S. health officials ... health conditions, such as asthma or diabetes, as well as ...
... Mass., Sept. 8 Caliper Life Sciences, Inc. (Nasdaq: ... present at the UBS Global Life Sciences Conference in New York ... , , A live webcast of the ... replay of the webcast will be available for 30 days following ...
... , AUSTIN, Texas, Sept. 8 Organix-South, ... the American Botanical Council,s (ABC) Adopt-an-Herb program ... three years, Organix-South will provide ABC with financial support to ... research on neem ( Azadirachta indica ) are made available ...
... , , , ... the country returns from the Labor Day holiday, world-class speedskater Katherine Reutter ... enters the US Olympic Short Track Speedskating Trials, in Marquette, MI. ... journey - officially earning a spot on the 2010 Olympic Team for ...
... Sept. 8 Allscripts (Nasdaq: MDRX ) announced today ... ended August 31, 2009 after the stock market closes on Tuesday, ... the same day, Allscripts management will host a conference call and ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) , ...
... suggest that symptoms stem from deficits in brain,s rewards ... trouble concentrating that affects people with attention-deficit hyperactivity disorder ... has found. , The motivational problems seen with the ... persist into adulthood, appear to stem from a reduction ...
Cached Medicine News:Health News:Antiviral Drugs Should Be Used Cautiously to Fight Flu, U.S. Says 2Health News:Antiviral Drugs Should Be Used Cautiously to Fight Flu, U.S. Says 3Health News:Organix-South Adopts Neem Through the American Botanical Council's Adopt-an-Herb Program 2Health News:Organix-South Adopts Neem Through the American Botanical Council's Adopt-an-Herb Program 3Health News:Organix-South Adopts Neem Through the American Botanical Council's Adopt-an-Herb Program 4Health News:It's Now or Never - Deadline for Olympic-Hopeful Skater With Secret Weapon 2Health News:Allscripts to Announce Fiscal First Quarter Results on September 29, 2009; Company Appoints Vice President of Investor Relations 2Health News:Allscripts to Announce Fiscal First Quarter Results on September 29, 2009; Company Appoints Vice President of Investor Relations 3Health News:Allscripts to Announce Fiscal First Quarter Results on September 29, 2009; Company Appoints Vice President of Investor Relations 4Health News:Allscripts to Announce Fiscal First Quarter Results on September 29, 2009; Company Appoints Vice President of Investor Relations 5Health News:Motivation May Be at Root of ADHD 2Health News:Motivation May Be at Root of ADHD 3
... generation of Urocap, features automatic ... stopping and printing. The advanced ... with superior low flow rate ... ICS nomenclature normative comparisons to ...
... Uro-Guide Open Tip Ureteral ... silicone over-the-wire stents and ... design with an open ... of time-tested biocompatible silicone ...
... the proper patient position during surgery is ... of ophthalmic procedures. Not every patient is ... and slight movements can compromise the procedure ... patient. The Rousseau chin-lift stabilizer eliminates the ...
... ECG technology - Until now, if you ... on some of your patients while continuing ... majority of patients, you had to keep ... all that has changed with Lifecard 12 ...
Medicine Products: